Kelly Lawrence W & Associates Inc Johnson & Johnson Transaction History

Kelly Lawrence W & Associates Inc

  • $430 Million
  • Q3 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 62,353 shares of JNJ stock, worth $9.04 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
62,353
Previous 62,584 0.37%
Holding current value
$9.04 Million
Previous $9.15 Million 10.46%
% of portfolio
2.35%
Previous 2.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$145.48 - $167.38 $33,605 - $38,664
-231 Reduced 0.37%
62,353 $10.1 Million
Q2 2024

Aug 13, 2024
SELL
$144.38 - $157.78 $465,336 - $508,524
-3,223 Reduced 4.9%
62,584 $9.15 Million
Q1 2024

May 15, 2024
SELL
$155.22 - $162.74 $428,096 - $448,836
-2,758 Reduced 4.02%
65,807 $10.4 Million
Q4 2023

Feb 14, 2024
SELL
$145.6 - $158.88 $294,112 - $320,937
-2,020 Reduced 2.86%
68,565 $10.7 Million
Q3 2023

Nov 14, 2023
SELL
$155.75 - $174.48 $36,445 - $40,828
-234 Reduced 0.33%
70,585 $11 Million
Q2 2023

Aug 14, 2023
SELL
$154.35 - $166.11 $194,172 - $208,966
-1,258 Reduced 1.75%
70,819 $11.7 Million
Q1 2023

May 15, 2023
SELL
$151.05 - $180.26 $83,983 - $100,224
-556 Reduced 0.77%
72,077 $11.2 Million
Q4 2022

Feb 14, 2023
SELL
$160.2 - $179.79 $1.19 Million - $1.34 Million
-7,431 Reduced 9.28%
72,633 $12.8 Million
Q3 2022

Nov 15, 2022
SELL
$161.33 - $179.52 $104,057 - $115,790
-645 Reduced 0.8%
80,064 $13.1 Million
Q2 2022

Aug 15, 2022
SELL
$168.19 - $186.01 $99,904 - $110,489
-594 Reduced 0.73%
80,709 $14.3 Million
Q1 2022

May 16, 2022
BUY
$158.14 - $179.59 $11,069 - $12,571
70 Added 0.09%
81,303 $14.4 Million
Q4 2021

Feb 11, 2022
SELL
$155.93 - $173.01 $129,889 - $144,117
-833 Reduced 1.02%
81,233 $13.9 Million
Q3 2021

Nov 15, 2021
BUY
$161.5 - $179.47 $11,305 - $12,562
70 Added 0.09%
82,066 $13.3 Million
Q2 2021

Aug 16, 2021
BUY
$159.48 - $171.07 $72,563 - $77,836
455 Added 0.56%
81,996 $13.5 Million
Q1 2021

May 17, 2021
BUY
$153.07 - $170.48 $4.27 Million - $4.75 Million
27,868 Added 51.92%
81,541 $13.4 Million
Q4 2020

Feb 12, 2021
SELL
$137.11 - $157.38 $4.06 Million - $4.66 Million
-29,628 Reduced 35.57%
53,673 $8.45 Million
Q3 2020

Nov 13, 2020
SELL
$140.38 - $153.83 $5.88 Million - $6.44 Million
-41,883 Reduced 33.46%
83,301 $12.4 Million
Q2 2020

Aug 14, 2020
SELL
$128.81 - $155.51 $53,713 - $64,847
-417 Reduced 0.33%
125,184 $17.6 Million
Q1 2020

May 14, 2020
SELL
$111.14 - $153.99 $1.15 Million - $1.59 Million
-10,350 Reduced 7.61%
125,601 $16.5 Million
Q4 2019

Feb 14, 2020
SELL
$127.5 - $146.44 $75,862 - $87,131
-595 Reduced 0.44%
135,951 $19.8 Million
Q3 2019

Nov 14, 2019
SELL
$126.95 - $142.14 $74,900 - $83,862
-590 Reduced 0.43%
136,546 $17.7 Million
Q2 2019

Aug 14, 2019
BUY
$131.15 - $144.24 $89,837 - $98,804
685 Added 0.5%
137,136 $19.1 Million
Q1 2019

May 15, 2019
SELL
$125.72 - $139.79 $160,921 - $178,931
-1,280 Reduced 0.93%
136,451 $19.1 Million
Q4 2018

Feb 14, 2019
SELL
$122.84 - $147.84 $536,073 - $645,173
-4,364 Reduced 3.07%
137,731 $17.8 Million
Q3 2018

Nov 14, 2018
BUY
$121.58 - $142.88 $195,743 - $230,036
1,610 Added 1.15%
142,095 $19.6 Million
Q2 2018

Aug 14, 2018
BUY
$119.4 - $131.76 $20,895 - $23,058
175 Added 0.12%
140,485 $17 Million
Q1 2018

May 15, 2018
SELL
$125.1 - $148.14 $85,068 - $100,735
-680 Reduced 0.48%
140,310 $18 Million
Q4 2017

Feb 14, 2018
BUY
$131.22 - $143.62 $1.3 Million - $1.43 Million
9,942 Added 7.59%
140,990 $19.7 Million
Q3 2017

Nov 15, 2017
BUY
$129.47 - $135.38 $17 Million - $17.7 Million
131,048
131,048 $17 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email